RBRajaram Burrah

Rajaram Burrah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rajaram Burrah has a total of 94 co-authors. Here are the top co-authors by number of shared publications:

  • Suraj Manjunath

    Department of Surgical Oncology, St. John's Medical College Hospital, Sarjapura Road, Bangalore, 560034 India

    4 shared publications
  • K. Shivakumar

    Department of Surgical Oncology, St Johns' Medical College, Bangalore, India

    3 shared publications
  • Jonathan Lund

    Wirral Breast Unit, Wirral University Teaching Hospital, Clatterbridge Hospital, Wirral, Merseyside, CH63 4JY, UK

    2 shared publications
  • Karen James

    Wirral Breast Unit, Wirral University Teaching Hospital, Clatterbridge Hospital, Wirral, Merseyside, CH63 4JY, UK

    2 shared publications
  • Kuppuswamy Shivakumar

    Department of Surgical Oncology, St. John's Medical College Hospital, Bangalore, India

    2 shared publications
  • Manavalan Vijayakumar

    Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India

    2 shared publications

Latest Publications

  • Breast conservation surgery by round block mammoplasty

    by Rajaram Burrah, Karen James, Jonathan Lund, Raman Vinayagam


  • Parathyroid Carcinoma in Hyperparathyroidism Jaw Tumor Syndrome

    by Rajaram Burrah, Susheel Jain, Nalini Waghmore, Vivek Mathew, Elvis Joseph


  • Evaluation of Radiation Exposure During Sentinel Lymph Node Biopsy in Breast Cancer: A Retrospective Study

    by Rajaram Burrah, Karen James, Shabbir Poonawala

    Introduction: Sentinel node biopsy (SNB) is the standard of care for nodal staging in breast cancer. Currently, radioisotope‐guided SNB is the standard technique. We have undertaken this study to analyse radiation exposure during SNB for breast cancer over a significant period of time.Methods: The study was conducted over a period of 41 months and included 183 patients. The radioisotope was usually administered the day preceding the surgery at a dose of 40 MBq (±10%), and a lower dose of 20 MBq (±10%) was given if injected on the day of surgery. The radiation exposure was measured by dosimeters worn by the surgeon and surgical assistant.Results: The surgical procedures performed were mastectomy and SNB (56 patients), wide local excision and SNB (109 patients), and SNB alone (18 patients). The median time interval between the injection and surgery was 19.3 h, and median duration of surgery 93 min. The annual exposure for the surgeon was 0.125 mSv (range 0.01–0.03 mSv) and for the assistant was 0.265 (range 0.01–0.13 mSv).Conclusion: Contrary to other studies, we found the radiation exposure in the assistant was higher than that in the surgeon and we think this is because the assistant is positioned closer to the injection site during the procedure. However, the cumulative levels of radiation with SNB were very low and significantly below the permissible limits. The timing of injection, type of breast surgery and duration of procedure did not affect the levels of radiation exposure.


  • Abstract P5-15-07: Breast surgery – Is routine 'group & save' required? A quality improvement project

    by R Burrah, W Chicken, S Sathananthan

    Introduction Breast surgery, especially for malignant disease, is not associated with significant blood loss and therefore rarely requires blood transfusions. Pre-operative protocols in our hospital and in most other centers routinely require a blood group screening process (group and save) for elective breast cancer surgery. The process of group and save (G&S) in our hospital requires two blood samples to be drawn with at least 30 minute interval in-between. It takes at least 40 minutes for the samples to get processed and the cost for each test is £2.12. The test is valid for a period of 5 days after which time it needs to be repeated. This process in busy hospitals is clearly time consuming, results in delays and is inconvenient for patients and medical staff. The aim of this study was to ascertain the number G&S performed and rate of post-operative blood transfusion for patients undergoing surgery for malignant breast disease. This was to establish if mandatory pre-operative G&S is necessary in all cases, and if the number of tests performed can be reduced. The second part of the study was to analyze the outcome after implementation of changes to reduce the number of G&S tests. Method Retrospective review of patient records who had surgeries for malignant breast disease from December 2015 to November 2016. Exclusion criteria included benign disease, flap reconstruction and breast surgery combined with another major procedure. Following the initial analysis, it was proposed that only the operating surgeon will request the test and that it will not be routinely requested by the pre-op assessment team. A re-audit was done prospectively to study the outcome of change in practice and close the audit loop. Results 151 cases were eligible for review. 97.35% (147 patients) had G&S, and the post-operative transfusion rate was 1.32% (2 patients). Following a change in protocol a significant fall in the testing (97.35% to 35.5%) was seen and there were no post-operative blood transfusions in this period. Conclusion This simple yet important audit showed that routine G&S did not contribute to the patient management, increased cost of treatment, caused patient inconvenience and consumed hospital personal time. The changes we implemented significantly reduced the frequency of this test and was cost effective to the trust. This study has now been converted into a Quality Improvement Project and through this we will continue to improve the results further. This project has also stimulated an interest in the General Surgery department, and other units are now considering changing their practice based on our results. Citation Format: Burrah R, Chicken W, Sathananthan S. Breast surgery – Is routine 'group & save' required? A quality improvement project [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P5-15-07.

  • Abstract P3-13-06: Breast conserving surgery by periareolar mammoplasty – Surgical and oncological outcomes

    by R Burrah, R Vinayagam, K James

    Background Periareolar mammoplasty is a volume displacement oncoplastic technique for patients with small to medium sized breasts. This approach provides good access for a safe excision for both central and peripheral lesions, especially for those in the upper half of the breast. Cosmetically it allows good reshaping of the breast, and contralateral symmetrisation is rarely required. This technique has the potential to replace the standard wide local excision for breast cancer. There is scarcity of data about the results of this procedure in the literature. We present a single surgeon experience with this technique in terms of surgical and oncological outcomes. Methods Retrospective review of patients' records from October 2013 to December 2017 was performed. The patients' demographics, tumour characteristics and the early oncological outcomes were studied. The postoperative complications and rate of symmetrisation were also studied. Results -There were 110 patients in this study period. The median age was 60 years (range 36 – 82 years) and screen detected tumours accounted for 66% (72 patients) of cases. -Neoadjuvant therapy was given in 14 patients (endocrine therapy – 12, chemotherapy – 1, dual targeted therapy – 1). -Most patients had the lesion in the upper half of the breast (upper outer-71, upper inner-33). -The average size of the tumour was 18.9mm (range 1.8 – 70mm) and the average weight of the excised specimen was 47.2gm (range 11-190gms). Invasive carcinoma was seen in 94 patients (85%) of which 86 patients had invasive ductal carcinoma, 4 had invasive lobular carcinoma and 4 had special type. Pure DCIS was present in 16 patients (15%). Most patients had grade 2 cancers (45%). DCIS was present with invasive carcinoma in 55% of cases. -Thirteen patients had positive margins (Citation Format: Burrah R, Vinayagam R, James K. Breast conserving surgery by periareolar mammoplasty – Surgical and oncological outcomes [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P3-13-06.

  • Occult primary malignant melanoma presented with a metastatic breast mass: A case report

    by A. Saad Abdalla, P. Idaewor, M. Elamass, T. Comez, R. Burrah, M. Barron, A. Asaad

  • Breast surgery– is routine group & save required?

    by Rajaram Burrah, Wayne Chicken, Saad Abdalla

  • One-stop breast clinic waiting-time reduction– a Quality improvement project (QIP)

    by Raman Vinayagam, Denise Mason, Rajaram Burrah, Shabbir Poonawala, Maria Callaghan, Jonathan Lund

  • Feasibility of Axillary Reverse Mapping and Clinicopathological Features Predicting ARM Node Metastasis in Breast Cancer—a Pilot Study

    by K. Shiva Kumar, G. N. Hemanth, Poonam K. Panjwani, Suraj Manjunath, Rakesh S. Ramesh, Rajaram Burrah, Pritilata Rout, D. Ramu, Elvis Peter Joseph, Ravi Chandran, et al.

    The axillary reverse mapping (ARM) technique has been described as an attempt to map and preserve the upper extremity lymphatic drainage during axillary lymph node dissection (ALND) and/or SLNB. This technique is based on the hypothesis that the lymphatic pathway from the upper extremity is not involved by metastasis from primary breast cancer. The ARM node/s however, has been found, in various studies, to be involved with metastatic foci in patients with extensive axillary lymph node metastases. Therefore, the oncological safety of this procedure has not yet been determined. In this pilot study, we assessed the ARM node intraoperatively for various parameters and compared it to final HPR, to try and determine the oncologic safety of preserving the ARM node. Seventy-two breast cancer patients were screened for this prospective pilot study which was planned to recruit 20 patients. The study was initiated on May 2014, 20 patients were recruited till July 2015. Eligibility criterion was as follows: patients requiring primary axillary lymph node dissection based on a clinically positive axilla. Forty-five patients were ineligible because they had either received neoadjuvant chemotherapy or underwent previous axillary surgery or axillary radiation (exclusion criteria). Seven patients refused to give consent. ARM node identification rate was 75%. The most common location of the ARM node was lateral to the latissimus dorsi pedicle (42.10%), none of them being malignant. None of the oval or firm nodes were malignant. Tumor deposits were identified in 13%. Fine-needle aspiration cytology (FNAC) had 100% specificity, 94.4% negative predictive value, 100% positive predictive value, and 50% sensitivity. ARM is feasible using blue dye alone, with an acceptable identification rate. Location, consistency, and intraoperative FNAC of the ARM node, put together, may be reliable parameters to predict involvement of the ARM node with metastasis.


  • Sentinel Lymph Node Biopsy in N0 Neck for Squamous Cell Carcinoma of Oral Cavity: a Prospective Study

    by K. Shivakumar, Goel Vipin, Manjunath Suraj, B. V. Rajaram, Ramesh Rakesh, A. Anuradha, K. Hemanth

    Oral cancers in India are very common. SLNB (sentinel lymph node biopsy) for the management of the cN0 neck provides proper staging with less morbidity. The study aims at assessment of the technical feasibility and accuracy of SLNB. Two by two table and Kappa statistic was used to compare SLN and END. In 14 cases out of 16 cases, SLN was identified. Sensitivity and specificity of 100 % were found. One hundred percent agreement was observed between SLN and END using kappa statistics. A meta-analysis of 19 studies showed 97.7 % sentinel node identification rate and 92.6 % sensitivity with a false negative rate of 3 %. In patients with N0 neck and negative SLN, neck dissection can be avoided decreasing morbidity of SOND. SLN biopsy has potential to become standard of care for managing N0 neck; however, long-term oncological results need to be evaluated.